Europe has emerged as a leader in addressing veterinary antimicrobial stewardship, exemplified by the sophisticated regulatory environments in the UK and the Netherlands. Both countries have implemented meticulous, mandatory surveillance mechanisms that capture every veterinary antimicrobial sale and use across the spectrum of livestock production. This high-resolution data collection is supported by active collaboration among veterinarians, farmers, regulatory agencies, and industry stakeholders, fostering a transparent and responsive governance model. This network enables policymakers to monitor antibiotic consumption trends in near real-time and design precision interventions aimed at curbing unnecessary or excessive use, thereby directly reducing the pressure driving resistance evolution.

In stark contrast, Brazil, a global powerhouse in meat production responsible for nearly 13% of the world’s animal protein supply, remains severely underprepared to tackle the AMR threat inherent in its agricultural practices. Despite Brazil’s economic weight and central role in the global food supply chain, the country currently lacks a cohesive national framework for veterinary antimicrobial monitoring. Sales data of veterinary antibiotics are not systematically collected or accessible to authorities, existing regulations are infrequently enforced, and there is a significant disconnect between official oversight and small-scale producers who operate largely outside regulatory reach. This fragmentation fundamentally cripples the capacity to assess antibiotic use accurately, identify misuse or overuse, and develop evidence-based policies to mitigate resistance risks.

The absence of robust antimicrobial surveillance in Brazil carries profound implications far beyond its borders. Resistant bacteria emerging in Brazilian livestock systems can easily spread internationally through exported meat products, threatening food safety and public health on a global scale. Furthermore, Brazil’s regulatory void poses a critical challenge to its agricultural export economy. As international markets increasingly demand transparent documentation verifying responsible antibiotic use, Brazil risks facing trade restrictions or loss of competitive advantage, jeopardizing one of its most valuable economic sectors. In this context, the effective monitoring and stewardship of veterinary antibiotics are not only public health imperatives but also strategic economic necessities.

A deeper technical examination reveals that the antimicrobial monitoring systems in the UK and the Netherlands integrate comprehensive digital databases that track antimicrobial sales at granular levels, enabling sector-specific interventions. These systems leverage advanced data analytics and reporting tools to identify hotspots of overuse or emerging resistance patterns in real-time, fostering an adaptive regulatory environment. Importantly, veterinarians in these countries are equipped with decision-support tools grounded in surveillance data, promoting responsible prescription practices aligned with One Health principles. This holistic approach demonstrates that synergistic stakeholder engagement coupled with rigorous data infrastructure is fundamental to containing AMR within livestock production.

Brazil’s challenges in establishing similar systems stem from multifaceted issues including infrastructural deficits, fragmented agricultural practices, and political complexities inhibiting regulatory enforcement. The current reliance on voluntary reporting and the absence of a centralized, interoperable database preclude effective nationwide surveillance. Moreover, socio-economic constraints among smallholders complicate the adoption of monitoring protocols, signaling the need for tailored capacity-building initiatives and incentivization mechanisms. Without addressing these systemic challenges, Brazil’s surveillance infrastructure will remain inadequate to meet both public health mandates and international trade expectations.

The study published in Science in One Health boldly calls for transformative reforms in Brazil aimed at closing these critical information gaps. It advocates for making antimicrobial sales and usage reporting mandatory across all layers of animal production, encompassing both large-scale exporters and small-scale farmers. Strengthening enforcement frameworks with credible penalties for non-compliance and aligning regulatory standards with international best practices are identified as essential steps to enhance transparency and accountability. The research also emphasizes the importance of cultivating robust partnerships between regulators, veterinary professionals, and producers to foster trust and facilitate the practical implementation of monitoring protocols.

Data empowerment emerges as a central theme in combating AMR effectively. Providing regulatory bodies with timely, reliable access to antimicrobial usage data allows for informed policymaking, early detection of resistance trends, and targeted interventions. The experience from European countries illustrates how integrating surveillance data into policy feedback loops can suffice not only in reducing antimicrobial consumption but also in preserving the efficacy of precious therapeutic agents critical to human and animal health. Without such data-driven governance, Brazil—and by extension the global community—remains vulnerable to unchecked resistance proliferation.

Ensuring global food safety necessitates concerted international cooperation, given that antimicrobial resistance does not recognize geopolitical boundaries. As the largest producer and exporter of multiple animal protein commodities, Brazil bears a heightened responsibility to harmonize its monitoring systems with global stewardship narratives. By embracing rigorous surveillance mechanisms and transparent reporting, Brazil can simultaneously safeguard public health, fulfill international trade obligations, and fortify its market competitiveness amidst increasing scrutiny on antimicrobial use in food production systems.

The findings of this new analysis highlight an urgent inflection point in the fight against AMR. While mature systems in Europe provide a proven blueprint for integrated antimicrobial stewardship, Brazil’s current state exposes dangerous vulnerabilities with global ramifications. However, the report offers a hopeful vision—one where strategic reforms and collaborative efforts can scaffold a comprehensive veterinary antimicrobial monitoring system that meets the highest standards of scientific rigor and regulatory efficacy. Such progress would mark a decisive leap forward in securing a safer, more sustainable food supply and preserving the therapeutic arsenal for future generations.

In conclusion, the battle against veterinary antimicrobial resistance demands immediate and sustained action grounded in robust surveillance and regulatory frameworks. The contrasting experiences of the UK, the Netherlands, and Brazil underscore the critical role of transparent data, stakeholder collaboration, and enforced policies in managing antibiotic use within animal agriculture. As antimicrobial resistance threatens to undermine decades of medical progress, global leadership—particularly from nations central to animal protein production—is indispensable. Brazil’s opportunity to transform its veterinary antimicrobial monitoring infrastructure represents not only an imperative public health investment but also a pivotal moment for global health security.

Subject of Research: Veterinary antimicrobial monitoring systems and antimicrobial resistance surveillance in animal agriculture

Article Title: Veterinary antimicrobial monitoring systems in Brazil, the United Kingdom, and the Netherlands: a descriptive comparison to support system development in Brazil

News Publication Date: 2-Apr-2026

Web References:
DOI:10.1016/j.soh.2026.100154

Image Credits: Jessica Kayamori Lopes, Briana Gomes, Bruno Machuca Thon, Saulo Henrique Weber, Ruan Rolnei Daros, Fernando Bittencourt Luciano, Claudia Turra Pimpao

Keywords: Antibiotics, Antimicrobial resistance, Veterinary medicine, Livestock, Surveillance systems, Regulatory frameworks, Brazil, United Kingdom, Netherlands, One Health, Food safety, Global health

The entanglement of antimicrobial resistance within and across the three intersecting domains of “One Health”—humans, animals, and the environment—amplifies the complexity of this crisis. Unlike classical infectious diseases limited to a single host or ecosystem, resistance genes traverse these boundaries continually, propelled by numerous direct and indirect pathways of transmission. These include not only clinical misuse and agricultural overuse of antimicrobials but also widespread contamination of environmental compartments such as water bodies and soils. This multifaceted connectivity of resistance determinants enhances the global burden of AMR and complicates containment efforts.

Historically, AMR genes evolved as natural defensive mechanisms amongst microbes competing for ecological niches. However, anthropogenic activities, particularly the prolific deployment of antimicrobials in medicine, farming, and aquaculture, have exponentially increased selective pressure that favors resistant strains. This selective amplification leads to the enrichment and mobilization of ARGs, facilitating horizontal gene transfer mechanisms among distinct bacterial populations. Mobile genetic elements such as plasmids, integrons, and transposons play a vital role in this genetic interplay, allowing ARGs to jump species barriers and spread rapidly in microbial communities.

One of the pivotal challenges lies in the environmental dimension of AMR dissemination. Aquatic environments, in particular, serve as dynamic reservoirs and conduits for resistance genes. Pollutants originating from human sewage discharge, agricultural runoff laden with antimicrobial residues, and industrial effluents create hotbeds for the proliferation and exchange of AMR determinants in natural water systems. These ecosystems, often understudied in antimicrobial resistance surveillance, represent crucial nodes where cross-sectorial transmission is facilitated, linking clinical, agricultural, and environmental settings.

The concept of One Health places imperative emphasis on understanding AMR not merely as a clinical or agricultural problem but as a highly interconnected issue requiring integrated action. This framework calls for collaborative surveillance systems, data-sharing, and harmonized policy interventions encompassing human medicine, veterinary practices, and environmental management. However, despite widespread recognition of this interconnectedness, actual implementation of effective AMR National Action Plans remains suboptimal in many regions, particularly low- and middle-income countries where resource constraints, infrastructural deficits, and lack of technical expertise hinder comprehensive monitoring and control.

A major impediment to advancing global AMR control efforts is the insufficient elucidation of the connectivity patterns by which resistance genes move among the One Health sectors. This knowledge gap undermines the ability to target interventions strategically and hampers predictive modeling of AMR trajectories. Novel approaches leveraging high-throughput genomic and metagenomic technologies offer unprecedented resolution in deciphering these complex transmission networks. By sequencing microbial communities directly from diverse sources—wastewater, livestock environments, clinical samples—researchers can map ARG distributions, trace their origins, and identify critical transmission hotspots.

Metagenomics, in particular, circumvents the need to culture microbes, enabling comprehensive characterization of resistomes across entire ecosystems. This powerful tool can uncover ARGs harbored by uncultivable or rare bacterial populations, providing insights into hidden reservoirs and transmission vectors. Coupling genomic data with metadata on antimicrobial usage, environmental conditions, and host interactions allows for constructing integrative models that reveal the interplay between selective pressures and genetic mobility driving AMR dynamics.

Understanding AMR connectivity at the ecological level entails studying how microbial communities interact within environmental niches, shaping the selection and maintenance of resistance traits. At the microbial level, investigating the mechanisms facilitating horizontal gene transfer—including conjugation, transduction, and transformation—sheds light on how resistance genes migrate between species and genera. Meanwhile, at the genetic level, detailed analyses of ARG sequences, their genetic contexts, and associated mobile elements are critical for identifying evolutionary pathways and potential points of intervention.

Addressing AMR through the One Health lens also requires recognizing socio-economic and behavioral factors influencing antimicrobial use and environmental contamination. In many low-resource settings, lack of regulation, inadequate wastewater treatment, and unmonitored antibiotic sales contribute to uncontrolled antimicrobial exposure and resistance proliferation. Thus, combating AMR necessitates multi-sectoral policies encompassing improved stewardship, sanitation infrastructure enhancement, and public awareness campaigns tailored to local contexts.

International efforts aimed at halting AMR progression must prioritize integrated cross-sector studies that bridge human health, veterinary medicine, and environmental science. Such multidisciplinary research collaborations foster standardized methodologies, enabling comparability of data across regions and facilitating global surveillance networks. This harmonization is essential not only for tracking global trends but also for informing evidence-based regulatory strategies and fostering investments aligned with the global burden of antimicrobial resistance.

The urgency of this global health threat calls for enhanced funding and political commitment to support genomic and metagenomic research focused on AMR connectivity. Investments are needed to build capacity in regions vulnerable due to limited technical infrastructure, ensuring equitable participation in global surveillance efforts. Additionally, promoting open-access data platforms will accelerate knowledge exchange and empower policymakers to devise informed, adaptive responses.

Mitigating the spread of AMR demands innovative intervention strategies informed by connectivity insights. For instance, identifying critical control points within environmental reservoirs—such as wastewater treatment plants where ARG concentrations peak—can guide targeted mitigation measures, including advanced filtration technologies or bioremediation approaches. Similarly, modifying agricultural practices to reduce prophylactic antimicrobial use and improve animal husbandry can lower selective pressures that drive resistance emergence.

The integration of cutting-edge technologies with the One Health model holds promise for transforming AMR management from reactive containment to proactive prevention. Genomic surveillance offers real-time monitoring capabilities to detect emerging resistance mechanisms promptly and to evaluate intervention effectiveness over time. Through continuous data feedback loops, this dynamic approach can enable rapid adjustments in treatment guidelines, antimicrobial usage policies, and environmental management practices.

Ultimately, the fight against antimicrobial resistance is a race against time, requiring synchronized actions transcending disciplinary and geographical borders. Recognizing the fundamental role of connectivity in spreading resistance genes across human, animal, and environmental interfaces is paramount. By harnessing genomics and metagenomics as powerful tools to map these connections, and by fostering cross-sector collaborations, the global community can better anticipate, respond to, and contain the AMR threat.

In conclusion, antimicrobial resistance represents a multifaceted crisis shaped by the intricate interplay of genetic, microbial, and ecological factors within the One Health framework. Concerted efforts to understand and disrupt connectivity pathways underpin the future of AMR mitigation. As we stand on the cusp of genomic innovation and global cooperation, scaling up integrated surveillance and harmonized interventions offers a hopeful pathway toward safeguarding the effectiveness of antimicrobials for generations to come.

Subject of Research: Antimicrobial resistance (AMR) connectivity across humans, animals, and the environment within the One Health framework.

Article Title: Assessing antimicrobial resistance connectivity across One Health sectors.

Article References:
Li, L., Li, B., Yin, X. et al. Assessing antimicrobial resistance connectivity across One Health sectors. Nat Water (2025). https://doi.org/10.1038/s44221-025-00514-8

Image Credits: AI Generated